Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s):  MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.


CSE:MYCO - Post by User

Post by vitalina2233on Apr 27, 2021 1:12pm
222 Views
Post# 33075098

response

responseHi XXXXXX
 
The company filed a NASDAQ application in January 2021 and are working to meet all the requirements set by the exchange. We hope to update our valued shareholders in the near future.



Best,
 
On Tue, Apr 27, 2021 at 9:30 AM Ernesto DiSalvo <f> wrote:
Hi Charles, hope your well. Investors are eagerly awaiting the next move to the Naz. Is their anything you can share with us  at this time. I seen a stock in our space on the Naz up over 800% this year ,sorry can’t recall the name. Any info would be helpful as you see we have penny flippers out there that are bashing the stock  Thanks
 
Sent from Mail for Windows 10
 
--
 
Charles Lee
Investor Relations,  Mydecine Innovations Group Inc.
+1 (720) 277-9879 | clee@mydecineinc.com
www.mydecine.com 
 
| NEO Symbol: MYCO
 
 

<< Previous
Bullboard Posts
Next >>